Puma Biotechnology (PBYI) Non Operating Income (2017 - 2025)
Historic Non Operating Income for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to -$330000.0.
- Puma Biotechnology's Non Operating Income rose 7756.63% to -$330000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 6579.59%. This contributed to the annual value of -$6.9 million for FY2024, which is 3110.58% up from last year.
- As of Q3 2025, Puma Biotechnology's Non Operating Income stood at -$330000.0, which was up 7756.63% from -$471000.0 recorded in Q2 2025.
- In the past 5 years, Puma Biotechnology's Non Operating Income registered a high of $11.6 million during Q2 2021, and its lowest value of -$35.7 million during Q3 2021.
- Its 5-year average for Non Operating Income is -$3.8 million, with a median of -$2.4 million in 2021.
- Per our database at Business Quant, Puma Biotechnology's Non Operating Income skyrocketed by 40972.15% in 2021 and then tumbled by 53973.29% in 2022.
- Over the past 5 years, Puma Biotechnology's Non Operating Income (Quarter) stood at -$2.4 million in 2021, then plummeted by 539.73% to -$15.3 million in 2022, then skyrocketed by 86.99% to -$2.0 million in 2023, then skyrocketed by 43.48% to -$1.1 million in 2024, then soared by 70.72% to -$330000.0 in 2025.
- Its Non Operating Income was -$330000.0 in Q3 2025, compared to -$471000.0 in Q2 2025 and -$717000.0 in Q1 2025.